Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Analytical Methods : Advancing Methods and Applications|January 10, 2023
Preparation of Au-RGO/TiO2 nanotubes and study on the photocatalytic degradation of ciprofloxacinJinlong Zuo, Xuewei Ma, Chong Tan, et al.
International Journal of Biological Macromolecules|October 10, 2024
Selenium polysaccharide form sweet corn cob mediated hypoglycemic effects in vitro and untargeted metabolomics study on type 2 diabetesJingyang Wang, Xin Wang, Weiye Xiu, et al.
Foods (Basel, Switzerland)|February 27, 2026
Structural and Metabolic Remodeling of Mixed Lactic Acid Bacteria-Fermented Wheat Germ and Its In Vitro and In Vivo Digestive StabilityZhenguo Liu, Dong Liang, Xin Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker AnalysisWenya Wu, Yunsong Yang, Wentao Yang, et al.
Advances in Therapy|December 5, 2018
Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational StudyHui Xie, Jinping Liu, Shiyou Yu, et al.
Frontiers in Oncology|August 2, 2021
Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World StudyLili Zhang, Xiaohong Wu, Jun Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.
Breast Cancer Research : BCR|May 6, 2025
8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trialBiyun Wang, Xiuchun Chen, Hongtao Li, et al.
Pageof 2